Harnessing Biomarker Signatures for Phenotypic Stratification in IBD: Leveraging a Precision Medicine approach to maximize the mechanistic potential of ESN-X
Time: 11:30 am
day: Conference Day Two
Details:
- Deep molecular phenotyping addresses the complexities of the underlying biology in IBD.
- Multi-omics and machine learning enable identification of patients most likely to benefit from specific drugs.
